๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shanghai

3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Effectiveness, Stability and Influence Factors of Femtosecond Laser Assisted Cataract Surgery
NCT07081919Corneal Astigmatism, Cataract
Eye & ENT Hospital of Fudan University
Observational
105
Shanghai
2025-04-22
Recruiting
Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma
NCT06987916B Cell Lymphoma
Shanghai Tongji Hospital, Tongji University School of Medicine
Phase 1/2
50
Shanghai
2025-04-22
Recruiting
MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC
NCT07235566Thyroid Cancer
Fudan University
Phase 2
60
Shanghai
2025-04-21
Recruiting
Study on the Effectiveness and Safety of Temporal Interference Stimulation in Treating Patients With Severe Consciousness Disorders
NCT06896279Disorder of Consciousness, Temporal Interference Stimulation
Huashan Hospital
Not applicable
20
Shanghai
2025-04-21
Recruiting
RGL-305+ Lymphoma + Exploratory Clinical Study
NCT07006012Lymphoma Patients With Complete Response (CR) or Partial Response (PR) After Standard Treatment Had a Positive Minimal Residual Lesion (MRD)
Fudan University
Not applicable
12
Shanghai
2025-04-21
Recruiting
Effect of Surgical Margin Width on Recurrence and Survival in Patients With Hepatic Oligometastasis of Colorectal Cancer
NCT06934018Oncology, Tumor Recurrence and Metastasis
Fudan University
Not applicable
140
Shanghai
2025-04-21
Recruiting
TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC
NCT06914297Endometrial Cancer
Fudan University
Phase 2
10
Shanghai
2025-04-21
By invitation
Breast Cancer PET/CT Imaging With 68Ga-pAKTi
NCT06943313Breast Cancers, PIK3CA Mutation-Related Tumors, PI3K Pathway Activated Tumors, PET / CT
Fudan University
Observational
20
Shanghai
2025-04-21
Recruiting
A Clinical Study Evaluating the Application of La Roche-Posay's New B5 Multi-Effect Soothing and Repairing Cream on Individuals With Facial Atopic Dermatitis
NCT07022288Atopic Dermatitis of Face
ChinaNorm
Not applicable
76
Shanghai
2025-04-20
Recruiting
Validation of Five Seasons Sleep Tracking Mat for the Diagnosis of Obstructive Sleep Apnea
NCT06875479Obstructive Sleep Apnea (OSA)
Shanghai 6th People's Hospital
Observational
400
Shanghai
2025-04-20
Recruiting
Cryoablation vs Thoracoscopic Surgery for GGN
NCT06848881Ground-Glass Opacity
Shanghai Chest Hospital
Not applicable
160
Shanghai
2025-04-20
Active, closed
Efficacy of Mavacamten in Patients With Symptomatic Latent Obstructive Hypertrophic Cardiomyopathy
NCT06947590HCM - Hypertrophic Cardiomyopathy, Mavacamten
Xu Liu
Not applicable
78
Shanghai
2025-04-20
Active, closed
Gamified Digital Balance Assessment
NCT07088848Disease Prevention
Shanghai Jiao Tong University School of Medicine
Not applicable
30
Shanghai
2025-04-20
Not yet open
Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer
NCT06941987Minimal Residual Disease, Pancreatic Cancer Resectable
Shanghai Zhongshan Hospital
Observational
66
Shanghai
2025-04-20
Recruiting
An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa
NCT06936787Retinitis Pigmentosa
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 1
21
Shanghai
2025-04-20
Recruiting
IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
NCT06974812Unresectable Locally Advanced or Metastatic Solid Tumors
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1/2
250
Fuzhou, Changsha, Shanghai
2025-04-18
Recruiting
Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases
NCT07134153Breast Cancer
Fudan University
Phase 1/2
139
Shanghai
2025-04-18
Recruiting
Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCC
NCT06935188Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
98
Shanghai
2025-04-17
By invitation
Predicting the Metabolic Biomarkers Associated With Injury in Athletes
NCT06888635Sports Medicine
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
60
Shanghai
2025-04-16
Recruiting
A Phase II Study of HLX22 in Combination With Trastuzumab Deruxtecan in HER2-low, Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer Patients
NCT06832202HER2-low Hormone Receptor Positive Breast Cancer
Shanghai Henlius Biotech
Phase 2
50
Shanghai
2025-04-16
Recruiting
Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome
NCT06842524Polycystic Ovary Syndrome (PCOS)
Shanghai Zhongshan Hospital
Phase 2
150
Xiamen, Shanghai, Wenzhou
2025-04-16
Not yet open
Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
NCT06916975Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic
Jin Xu
Phase 2
46
Shanghai
2025-04-15
Not yet open
A Randomized Trial of the Rapamycin Target Eluting Stent for the Treatment of Symptomatic Cerebral Artery Atherosclerotic Disease๏ผˆTARGET-DREAM๏ผ‰
NCT06925971Intracranial Arteriosclerosis
MicroPort NeuroTech Co., Ltd.
Phase 3
279
Shanghai
2025-04-15
Recruiting
Electrical Impedance Tomography-Based Prognostic Model for ARDS
NCT06967207Acute Respiratory Distress Syndrome (ARDS), Ventilator-induced Lung Injury
XiaoJing Zou,MD
Observational
625
Guangzhou, Wuhan, Shanghai
2025-04-15
Recruiting
Fecal Microbiota Transplantation for Obese Women With Polyendocrine Metabolic Ovarian Syndrome
NCT07746635PCOS (Polycystic Ovary Syndrome)
Shanghai Changzheng Hospital
Not applicable
161
Shanghai
2025-04-15
Recruiting
Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO
NCT07152392Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital
Phase 4
50
Shanghai
2025-04-15
Active, closed
Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
NCT06914687Gastric Adenocarcinoma, Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma, Peritoneal Metastasis
Fudan University
Phase 2
30
Shanghai
2025-04-15
Recruiting
Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.
NCT07152366Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital
Phase 4
96
Shanghai
2025-04-15
Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
NCT06858813Hepatocellular Cancer, Squamous-Cell Non-Small Cell Lung Cancer
AbbVie
Phase 1
232
Guangzhou, Shanghai
2025-04-14
Recruiting
Natural Course and Therapeutic Effect of Chronic Pancreatitis
NCT06925204Chronic Pancreatitis
Changhai Hospital
Observational
5,000
Shanghai
2025-04-13
Recruiting
Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections
NCT07089186Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP), Complicated Intra-abdominal Infection (cIAI), Complicated Urinary Tract Infection (cUTI)
Qilu Pharmaceutical Co., Ltd.
Phase 3
80
Shanghai
2025-04-12
Recruiting
IVIG Trial for the Treatment of Bronchopulmonary Dysplasia
NCT06925360Bronchopulmonary Dysplasia
International Peace Maternity and Child Health Hospital
Phase 2
20
Shanghai
2025-04-12
Recruiting
18F FDG and 68Ga FAPI PET/MR Imaging of Carotid Artery Plaque Vulnerability: A Clinical Study in Carotid Artery Plaque Patients
NCT07004673Carotid Artery Plaque, Ischemic Stroke, PET / MR
Ruijin Hospital
Observational
100
Shanghai
2025-04-12
Recruiting
Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion
NCT06968572Advanced Solid Tumors
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
245
Guiyang, Nanjing, Shanghai
2025-04-11
Recruiting
First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant Tumors
NCT06877650Advanced Malignant Tumors
Shanghai JMT-Bio Inc.
Phase 1/2
436
Shanghai
2025-04-11
Recruiting
A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Initial Efficacy of JS212 in Subjects With Advanced Malignant Solid Tumour
NCT06888830Advanced Malignant Solid Tumours
Shanghai Junshi Bioscience Co., Ltd.
Phase 1/2
374
Shanghai
2025-04-11
Recruiting
Universal CAR-T Cell Therapy for MM
NCT07248176Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Bioray Laboratories
Not applicable
6
Shanghai
2025-04-10
Recruiting
The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines.
NCT06930118Advanced Colorectal Cancer in the Third-line Treatment and Beyond, pMMR/MSS Advanced Colorectal Cancer
Shanghai Changzheng Hospital
Phase 2
60
Shanghai
2025-04-10
Recruiting
TCM Daoyin for Anxiety/Depression: Psychological Effects and Biological Mechanisms
NCT06921512Anxiety Symptom, Depression Symptom
Shanghai University of Traditional Chinese Medicine
Not applicable
20
Shanghai
2025-04-10
Recruiting
The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.
NCT07152340Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital
Phase 4
64
Changhua, Shanghai
2025-04-10
Not yet open
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
NCT06926582Psoriasis
Hansoh BioMedical R&D Company
Phase 2
305
Shanghai
2025-04-09
Recruiting
Neoadjuvant SNF Precision Therapy Phase III
NCT06913777Neoadjuvant Therapy
Fudan University
Phase 3
404
Shanghai
2025-04-08
Active, closed
BCG for Therapeutic Use Phase โ…ข Clinical Trial
NCT06747455BCG
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Phase 3
439
Shanghai
2025-04-08
Recruiting
CAR-NK Cells (CL-NK-001) in Pancreatic Cancer
NCT06816823Pancreatic Cancer
Changhai Hospital
Phase 1
30
Shanghai
2025-04-07
Recruiting
Treatment of Perioperative Neurocognitive Disorders With Olfactory Enrichment
NCT06488807Perioperative Neurocognitive Disorder
Shanghai 10th People's Hospital
Not applicable
686
Shanghai
2025-04-07
Recruiting
Differences in Prosocial Behaviors and Related Brain Networks in Children With Autism and Typical Development
NCT06908174Autism Spectrum Disorder, Healthy
Children's Hospital of Fudan University
Observational
300
Shanghai
2025-04-07
Recruiting
Molecular Subtyping of Breast Cancer-derived Small Extracellular Vesicles (sEVs) to Predict Therapeutic Efficacy
NCT07574749Breast Cancer
Fudan University
Observational
1,500
Shanghai
2025-04-07
Recruiting
The C-BRIDGE Study: China Bronchiectasis Research Involving Databases, Genomics, and Endotyping
NCT06900062Bronchiectasis Adult
Shanghai Pulmonary Hospital, Shanghai, China
Observational
1,500
Guiyang, Changchun, Jinan, Shanghai, Jiaxing
2025-04-06
Not yet open
Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC
NCT06916117Locally Advanced Cervical Cancer
RenJi Hospital
Phase 2
30
Shanghai
2025-04-05
Recruiting
Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD
NCT06828887MDD
Vigonvita Life Sciences
Phase 2
400
Shanghai
2025-04-03
Active, closed
Clinical Study on the Safety and Efficacy of Immunophenotyped Pancreatic Endocrine Organoid Bank in Treating Patients With T3c Diabetes
NCT06991829Diabetes Mellitus
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
29
Shanghai
2025-04-03
Recruiting
The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial
NCT06946901Hyperthermic Intraperitoneal Chemotherapy, Peritoneal Metastatic Pancreatic Cancer
Shanghai Zhongshan Hospital
Phase 2
90
Changsha, Shanghai
2025-04-03
Recruiting
Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
NCT07348302Rhinitis, Rhinoconjunctivitis
Inmunotek S.L.
Phase 3
736
Beijing, Guangzhou, Zhongshan, Xiangya, Changzhou, Qingdao, Shanghai, Tongji
2025-04-02
Recruiting
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
NCT06346600Neovascular (Wet) Age-related Macular Degeneration
Skyline Therapeutics
Observational
83
Hefei, Hangzhou, Wenzhou, Beijing, Shanghai
2025-04-02
Recruiting
Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC
NCT06846450Nasopharyngeal Cancinoma (NPC)
Lin Kong, MD
Phase 3
470
Shanghai
2025-04-01
Active, closed
Acute Myocardial Infarction Clinical Cohort
NCT07522164Acute Myocardial Infarction
Shanghai Zhongshan Hospital
Observational
2,000
Shanghai
2025-04-01
Recruiting
Child-Parent Familial Hypercholesterolemia Screening
NCT04529967Familial Hypercholesterolemia
Children's Hospital of Fudan University
Observational
15,000
Hefei, Qidong, Shanghai, Taiyuan, Chongqing, รœrรผmqi
2025-04-01
Recruiting
RIRS With Flex Suction Sheath vs. PCNL for 2-3 cm Renal Stones
NCT07058402Nephrolithiasis
Changhai Hospital
Not applicable
308
Shanghai
2025-04-01
Active, closed
D615L vs Zeiss 839MP: Visual Quality
NCT07571694Cataract
Shanghai 10th People's Hospital
Observational
90
Shanghai
2025-04-01
Recruiting
Shanghai Clinical Cohort - Parkinson's Disease (Reserve)
NCT07353463Parkinson's Disease (PD), Multiple System Atrophy
Ruijin Hospital
Observational
700
Shanghai
2025-04-01
Recruiting
High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed
NCT06972602Retinoblastoma, Retinoblastoma, Recurrent
Eye & ENT Hospital of Fudan University
Phase EARLY_PHASE1
10
Shanghai
2025-04-01
By invitation
Protective Effect of Ulinastatin and Thymosin ฮฑ1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA XI)
NCT06966687Aortic Dissection, Aortic Dissection Aneurysm
Nanjing Medical University
Not applicable
200
Beijing, Guangzhou, Shanghai, Chengdu
2025-04-01
Active, closed
Exploration of Risk Factors for Postoperative Cerebral Infarction in Lung Cancer Patients: a Retrospective Single-centre Study
NCT06942845Lung Cancer, Non-Small Cell, Postoperative Cerebral Infarction
Xinghua Cheng
Observational
300
Shanghai
2025-04-01
Recruiting
EBUS-TTFB vs EBUS-TBNA for Diagnosing Inadequate Lymph Node Specimens Based on MOSE
NCT06913569Lymphadenopathy
Shanghai Chest Hospital
Not applicable
162
Shenyang, Shanghai, Huizhou
2025-04-01
Recruiting
A National Multicenter Survey on Small Vulnerable Newborns
NCT07143825Preterm, Small Gestational Age (SGA)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
2,000
Shanghai
2025-04-01
Recruiting
CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas
NCT06925464T-Cell Non-Hodgkin Lymphoma, T-cell Lymphoma (PTCL and CTCL)
Beijing GoBroad Hospital
Phase 1/2
36
Beijing, Zhanjiang, Shanghai
2025-04-01
Recruiting
Shanghai Clinical Cohort of Hyperglycemia in Pregnancy
NCT07161947Hyperglycemia in Pregnant Diabetic Patients, Gestatiaonl Diabetes Mellitus
Shanghai General Hospital, China
Observational
4,000
Shanghai
2025-04-01
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
Sanofi
Phase 3
300
Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Shanghai, Wuhan
2025-04-01
Not yet open
Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells (IxCell hUC-MSC-P) in the Treatment of CTD-ILD
NCT06823063CTD-ILD
Shanghai IxCell Biotechnology Co., LTD
Phase 1
18
Shanghai
2025-04-01
Recruiting
A Study on the Changes of Glucose Metabolism and Exocrine Function in Patients With Chronic Pancreatitis
NCT07314489Chronic Pancreatitis Pancreatic Exocrine Insufficiency Blood Glucose
Shanghai Changzheng Hospital
Phase EARLY_PHASE1
80
Shanghai
2025-04-01
Recruiting
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
NCT06873945Alopecia Areata
Pfizer
Phase 3
674
Beijing, Chongqing, Guangzhou, Changsha, Nanchang, Shanghai, Chengdu, Kunming
2025-04-01
Not yet open
HIM Typing Guides the Treatment of Advanced First-Line Triple-Negative Breast Cancer
NCT06849492Advanced Triple Negative Breast Cancer
Fudan University
Phase 2
120
Shanghai
2025-04-01
Recruiting
Efficacy and Safety of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL
NCT06803693Diffuse Large B-Cell Lymphoma
Ruijin Hospital
Phase 2
152
Shanghai
2025-04-01
Recruiting
Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism
NCT06946732Pulmonary Embolism (PE)
RenJi Hospital
Not applicable
127
Shanghai
2025-04-01
Not yet open
The Treatment of Newly Diagnosed CD19+Mixed Phenotype Acute Leukemia in Adults
NCT06876701Acute Leukemia
Ruijin Hospital
Phase EARLY_PHASE1
10
Shanghai
2025-04-01
Not yet open
Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAg
NCT06900166Chronic Hepatitis B
Huashan Hospital
Phase 4
360
Shanghai
2025-04-01
Not yet open
Mechanistic Study of EBV mRNA Vaccine (WGc-043) in EBV-Positive Relapsed/Refractory Lymphoma
NCT06788600Epstein-Barr Virus Associated Lymphoma
Ruijin Hospital
Observational
15
Shanghai
2025-04-01
Recruiting
A Randomized Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy Decision-Making in High-Risk Stage III (T4N+ or T1-3N2) Colorectal Cancer
NCT07562490ctDNA, Chemotherapy, Colorectal Cancer
Fudan University
Phase 2
100
Shanghai
2025-04-01
Not yet open
A Study to Evaluate the Efficacy and Safety of HLX15-IV Versus DARZALEXยฎ in Combination with Lenalidomide-Dexamethasone (Rd) in Transplant-ineligible Patients with Newly Diagnosed Multiple Myeloma
NCT06895512Newly Diagnosed Multiple Myeloma
Shanghai Henlius Biotech
Phase 3
386
Shanghai
2025-04
Not yet open
Efficacy and Safety of LC-Z300-01 on Proteinuria in Diabetic Patients
NCT06686758Diabetic Kidney Disease
Shanghai Changzheng Hospital
Not applicable
60
Shanghai
2025-04
Not yet open
Study of SLN12140 in Healthy Adult Participants
NCT06945445Healthy Volunteer
Linno Pharmaceuticals, Inc.
Phase 1
56
Shanghai
2025-04
Not yet open
GGO-dominant PPLs Diagnosis Using CLE and ssRAB-guided Cryobiopsy
NCT06910046Lung Ground-Glass Opacity
Shanghai Chest Hospital
Not applicable
119
Shanghai
2025-04
Recruiting
HANDLE-a Real World Study on Satralizumab in NMOSD
NCT06829524Neuromyelitis Optica Spectrum Disorders (NMOSD)
Huashan Hospital
Observational
100
Shanghai
2025-03-31
Not yet open
Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
NCT06888037Gastric Adenocarcinoma, GEJ Adenocarcinoma, First-line Therapy, Maintenance Therapy
Ruijin Hospital
Phase 2
55
Shanghai
2025-03-31
Recruiting
Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC
NCT07024680Papillary Renal Cell Carcinoma
AstraZeneca
Observational
150
Shanghai
2025-03-31
Not yet open
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria.
NCT06864507Chronic Spontaneous Urticaria
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1/2
150
Shanghai
2025-03-31
Recruiting
A Study of MHB118C Injection in Patients With Advanced Solid Tumors
NCT07045454Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1
200
Shanghai
2025-03-31
Not yet open
Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC
NCT06688656Lung Cancer
Shanghai Chest Hospital
Phase 2
30
Shanghai
2025-03-31
Recruiting
Phase III Trial of SYS6010 Versus Platinum-based Chemotherapy for EGFR-mutated NSCLC๏ผˆSYNSTAR01๏ผ‰
NCT06927986EGFR-mutated Locally Advanced or Metastatic NSCLC
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 3
380
Shanghai
2025-03-30
Recruiting
A Phase I/IIa Study of SYS6041 in Patients With Advanced Solid Tumors
NCT07744763Advanced Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 1/2
260
Shanghai
2025-03-28
Active, closed
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
NCT06867094Colitis Ulcerative
Sanofi
Phase 2
204
Guangzhou, Hangzhou, Huizhou, Jiazhuang, Linhai, Luoyang, Shanghai, Wuhan
2025-03-28
Active, closed
A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis
NCT06875934Moderate to Severe Plaque Psoriasis
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2
145
Shanghai
2025-03-28
Recruiting
Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease
NCT06725810Chronic Kidney Disease Associated Anemia
Shanghai Zhongshan Hospital
Phase 4
1,670
Shanghai
2025-03-27
Active, closed
Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC
NCT06895811Metastatic Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
Shanghai Changzheng Hospital
Phase 1
3
Shanghai
2025-03-27
Active, closed
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of GH2616 in Subjects With Advanced Solid Tumor.
NCT07260513Advanced Solid Tumor Cancer
Suzhou Genhouse Bio Co., Ltd.
Phase 1
126
Beijing, Shanghai
2025-03-27
Recruiting
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
NCT06795022Hepatocellular Carcinoma
AstraZeneca
Phase 1/2
304
Chengdu, Guangzhou, Harbin, Shanghai
2025-03-27
Recruiting
PDO Based Drug Sensitive Test in R/M HNSCC
NCT06686342Head and Neck Squamous Cell Carcinoma, Patient Derived Organoid, Drug Sensitive Test in Vitro
Huashan Hospital
Observational
100
Shanghai
2025-03-26
Recruiting
PDO Based Drug Sensitive Test in R/M SGC
NCT06686979Salivary Gland Cancers, Patient Derived Organoid, Drug Sensitive Test in Vitro
Huashan Hospital
Observational
40
Shanghai
2025-03-26
Recruiting
Glucose Pattern in Infertile Women Receiving Assisted Reproduction Using Continuous Glucose Monitoring
NCT06863337Infertility Female
Shanghai 6th People's Hospital
Not applicable
100
Shanghai
2025-03-26
Recruiting
A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Recurrent or Metastatic Urothelial Carcinoma(PANKU-Bladder01)
NCT06857175Urothelial Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
508
Shanghai
2025-03-25
Rows per page Showing 1601–1700 of 3827
Previous 15 16 17 18 19 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=17

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,827 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,393 of the 3,827 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 737 have not yet opened recruitment, 588 are active but closed to new participants, and 109 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.